Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"TNB-383B" - Google News
Get the latest updates from "TNB-383B" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated over 3 years ago
AbbVie expands neuroscience portfolio with Syndesi acquisition - Pharmaceutical Technology
over 3 years ago
AbbVie expands neuroscience portfolio with Syndesi acquisition Pharmaceutical Technology
AbbVie expands neuroscience portfolio with Syndesi acquisition - Pharmaceutical Technology
over 3 years ago
AbbVie expands neuroscience portfolio with Syndesi acquisition Pharmaceutical Technology
ABBVIE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - marketscreener.com
over 3 years ago
ABBVIE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF...
Multiple Myeloma Bispecifics Vie For Leadership Based On Safety, Combinability - Scrip
almost 4 years ago
Multiple Myeloma Bispecifics Vie For Leadership Based On Safety, Combinability Scrip
Therapeutic Frontiers Expand for Patients With Relapsed/Refractory Multiple Myeloma - OncLive
almost 4 years ago
Therapeutic Frontiers Expand for Patients With Relapsed/Refractory Multiple Myeloma OncLive
B Cell Maturation Antigen BCMA Targeted Drug Therapy Market - GlobeNewswire
almost 4 years ago
B Cell Maturation Antigen BCMA Targeted Drug Therapy Market GlobeNewswire
B Cell Maturation Antigen BCMA Targeted Drug Therapy Market - GlobeNewswire
almost 4 years ago
B Cell Maturation Antigen BCMA Targeted Drug Therapy Market GlobeNewswire
B Cell Maturation Antigen BCMA Targeted Drug Therapy Market Insight 2026 - EIN News
almost 4 years ago
B Cell Maturation Antigen BCMA Targeted Drug Therapy Market Insight 2026 EIN...
Ash 2021 preview – as competition grows Autolus monetises - Vantage
almost 4 years ago
Ash 2021 preview – as competition grows Autolus monetises Vantage
Therapeutic Frontiers for Relapsed/Refractory Multiple Myeloma Expand With CAR T and Bispecific Antibodies - OncLive
almost 4 years ago
Therapeutic Frontiers for Relapsed/Refractory Multiple Myeloma Expand With CAR T and Bispecific...
ABBVIE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com
almost 4 years ago
ABBVIE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF...
AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting - GuruFocus.com
almost 4 years ago
AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology...